We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Schering-Plough/Merck Joint Venture Files NDA for Rhinitis Drug
Schering-Plough/Merck Joint Venture Files NDA for Rhinitis Drug
August 31, 2007
Schering-Plough/Merck Pharmaceuticals, a joint venture between Schering-Plough and Merck, announced that the FDA has accepted its new drug application filing for an allergic rhinitis drug.